NM_001009944.3:c.11337C>G
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 2P and 14B. PM1BP4_StrongBP6_ModerateBS1BS2
The NM_001009944.3(PKD1):c.11337C>G(p.Ser3779Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000539 in 1,612,838 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Consequence
NM_001009944.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PKD1 | NM_001009944.3 | c.11337C>G | p.Ser3779Arg | missense_variant | Exon 40 of 46 | ENST00000262304.9 | NP_001009944.3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00287 AC: 437AN: 152180Hom.: 2 Cov.: 33
GnomAD3 exomes AF: 0.000766 AC: 191AN: 249446Hom.: 0 AF XY: 0.000612 AC XY: 83AN XY: 135546
GnomAD4 exome AF: 0.000294 AC: 429AN: 1460540Hom.: 3 Cov.: 33 AF XY: 0.000270 AC XY: 196AN XY: 726576
GnomAD4 genome AF: 0.00290 AC: 441AN: 152298Hom.: 2 Cov.: 33 AF XY: 0.00266 AC XY: 198AN XY: 74466
ClinVar
Submissions by phenotype
not specified Benign:1
- -
Polycystic kidney disease Benign:1
The PKD1 p.Ser3779Arg variant was identified in 1 of 478 proband chromosomes (frequency: 0.002) from individuals or families with ADPKD (Rossetti 2007). The variant was also identified in dbSNP (ID: rs116835405) as “With Benign allele”, ClinVar (1x, as benign by Prevention Genetics), ADPKD Mutation Database (as likely neutral). The variant was not identified in LOVD 3.0, or PKD1-LOVD databases. The variant was identified in control databases in 275 of 276024 (2 homozygous) chromosomes at a frequency of 0.000996 in the following populations: African at a frequency greater than 1%: in 254 of 23886 chromosomes (freq: 0.011), other in 2 of 6463 chromosomes (freq. 0.00031), Latino in 12 of 34408 chromosomes (freq. 0.00034), European in 7 of 125816 chromosomes (freq. 0.000055), increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Consortium Feb 27, 2017). This variant was also identified in our laboratory in one individual with ADPKD, co-occurring pathogenic PKD1 variant (c.8017-?_8161+?del), increasing the likelihood that the p.Ser3779Arg variant does not have clinical significance The p.Ser3779 residue is not conserved in mammals and four out of five computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) do not suggest a high likelihood of impact to the protein; however, this information is not predictive enough to rule out pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer, HumanSpliceFinder) do not predict a difference in splicing. The variant is located with the Polycystin cation channel, PKD1/PKD2 functional domain(s) increasing the likelihood that it may have clinical significance. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as likely benign. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at